24/7 Market News Snapshot 20 Jun 2024 – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

June 20, 2024 7:10

Press Release

DENVER, Colo., 20 June, 2024 (247marketnews.com) – (Nasdaq:TNXP) are discussed in this article.
Tonix Pharmaceuticals Holding Corp. (TNXP) demonstrated a robust performance in today’s trading session, showcasing a bullish trend with an impressive 20.74% price surge from the opening to the closing bell. The stock opened at $1.28 and closed at $1.34, underlining strong investor interest with a trading volume of 2.9 million shares. This positive market sentiment towards TNXP hints at potential upward momentum in the near future. Concurrently, the company announced significant advancements in its regulatory discussions with the FDA. In a recent press release, Tonix Pharmaceuticals disclosed successful alignment with the FDA on crucial Chemistry, Manufacturing, and Controls (CMC) matters, a critical stride in the drug approval process. The completion of the final pre-New Drug Application (NDA) meeting with the FDA signifies substantial progress, focusing on nonclinical, clinical pharmacology, and clinical aspects. These developments underscore Tonix Pharmaceuticals’ dedication to regulatory compliance and adherence to industry standards in its pursuit of innovative pharmaceutical solutions. With a focus on engaging constructively with regulatory authorities, the company aims to ensure product quality and safety. As Tonix Pharmaceuticals continues its regulatory journey, investors and stakeholders can anticipate further updates on regulatory milestones and the company’s commitment to addressing unmet medical needs with impactful pharmaceutical offerings.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.